Identification of New Human P2X7 Antagonists Using Ligand- and Structure-Based Virtual Screening
Journal of Chemical Information and Modeling · 2025
DOI: 10.1021/acs.jcim.5c00552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2025. Verfasst von Marika Zuanon und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences, Cardiff University, Sir Martin Evans Building, Cardiff CF10 3AT, United Kingdom. Hauptthemen laut MEDLINE: Receptors, Purinergic P2X7, Purinergic P2X Receptor Antagonists, User-Computer Interface. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sight Research UK, European Cooperation in Science and Technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biosciences, Cardiff University, Sir Martin Evans Building, Cardiff CF10 3AT, United Kingdom.
- Department of Organic Chemistry, University of Chemistry and Technology, Prague 166 28, Czech Republic.
ORCID-Profile: Andrea Brancale, Mark T Young
Förderung
- Sight Research UK
- European Cooperation in Science and Technology
Zitieren
APA
Zuanon, M., Brancale, A., & Young, M. T. (2025). Identification of New Human P2X7 Antagonists Using Ligand- and Structure-Based Virtual Screening. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.5c00552
Vancouver
Zuanon M, Brancale A, Young MT. Identification of New Human P2X7 Antagonists Using Ligand- and Structure-Based Virtual Screening. Journal of Chemical Information and Modeling. 2025. doi:10.1021/acs.jcim.5c00552
BibTeX
@article{Zuanon2025,
author = {Zuanon, Marika and Brancale, Andrea and Young, Mark T},
title = {Identification of New Human P2X7 Antagonists Using Ligand- and Structure-Based Virtual Screening},
journal = {Journal of Chemical Information and Modeling},
year = {2025},
doi = {10.1021/acs.jcim.5c00552}
}
EUVIMED